Finance

Beta
Lists
ABNX:EPA
Abionyx Pharma SA
€2.78
-0.89%
(-0.025) 1D
Jun 3, 5:35:07 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ABNX...
Open
€2.78
High
€2.81
Low
€2.72
Mkt. cap
116.61M
Avg. vol.
121.27K
Volume
188.07K
52-wk high
€5.21
52-wk low
€1.15
EPS
-€0.16
Shares outstanding
35.51M
No. of employees
49
Open
€2.78
High
€2.81
Low
€2.72
Mkt. cap
116.61M
Avg. vol.
121.27K
Volume
188.07K
52-wk high
€5.21
52-wk low
€1.15
EPS
-€0.16
Shares outstanding
35.51M
No. of employees
49
News stories
From sources across the web
About Abionyx Pharma SA
CEOCyrille Tupin
Employees49
Founded2005
Headquarters-
SectorBiotechnology
Websiteabionyx.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.06M
1.06M
972.00K
972.00K
Cost of goods sold
945.50K
945.50K
819.00K
819.00K
Cost of revenue
945.50K
945.50K
819.00K
819.00K
Research and development expenses
346.00K
346.00K
413.00K
413.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
938.00K
938.00K
1.35M
1.35M
Operating expense
1.28M
1.28M
1.76M
1.76M
Total operating expenses
2.22M
2.22M
2.58M
2.58M
Operating income
-1.16M
-1.16M
-1.60M
-1.60M
Other non operating income
11.00K
11.00K
-19.00K
-19.00K
EBT including unusual items
-1.15M
-1.15M
-1.62M
-1.62M
EBT excluding unusual items
-1.15M
-1.15M
-1.62M
-1.62M
Income tax expense
4.00K
4.00K
500.00
500.00
Effective tax rate
-0.35%
-0.35%
-0.03%
-0.03%
Other operating expenses
-5.00K
-5.00K
-5.00K
-5.00K
Net income
-1.15M
-1.15M
-1.62M
-1.62M
Net profit margin
-108.82%
-108.82%
-166.87%
-166.87%
Earnings per share
-
-
-
-
Interest and investment income
8.50K
8.50K
18.50K
18.50K
Interest expense
-26.50K
-26.50K
-16.00K
-16.00K
Net interest expenses
-18.00K
-18.00K
2.50K
2.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.13M
-1.13M
-1.58M
-1.58M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer